MAP3K5 and cancer: In summary, our systems biology modeling reveals that there is a stronger apoptotic potential existing in the EGFR-addicted cancers, which is largely suppressed by the negative crosstalk between PI3K/AKT and ASK1/p38 signaling pathways.